Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1–3 axillary lymph node(s) metastasis

Radiology and Oncology

Chou Fong-Fu¹  Wu Shih-Chung²  Chen Hui-Chun³  Tang Yen⁴  Li Shan-Hsuan⁵  Huang Cheng-Hua⁵  Rau Kun-Ming⁵  Chen Yen-Yang⁵  Su Yu-Li⁵ 

[1] Chang Gung University, College of Medicine, Taoyuan, Taiwan;Department of General Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan;Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan;Division of Hematology-Oncology, Department of Internal Medicine, E-Da Hospital, Kaohsiung, Taiwan;Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan;

关键词: breast cancer;    postmastectomy radiotherapy;    overall survival;    locoregional recurrence;    lymphovascular invasion;   

DOI  :  10.2478/raon-2013-0085

来源: DOAJ

【 摘 要 】

Background. To determine the role of postmastectomy radiotherapy (PMRT) in breast cancer patients with T1-2 and N1 disease.

【 授权许可】

Unknown